Open Accessibility Menu

Clinical Trials

Search Clinical Trials
All Clinical Trials
  • Advancing Surgical Cancer Care and Equity in the Deep South-ASCEND Colorectal, Pancreatic

    ASCENDS is a research study to develop a plan for improving the quality of surgery care for patients who are diagnosed with colorectal, esophageal and pancreatic cancer in Alabama and Mississippi. For phase one, we are conducting interviews with healthcare providers and cancer patients. In phase two, we will be surveying and conducting medical chart abstraction with 1,000 ...

    Continue Reading
  • Tomosynthesis Mammographic Imaging Screening Trial (TMIST) Breast

    This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment. For all information regarding this clinical trial ...

    Continue Reading
  • A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Breast

    This randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast cancer previously treated with chemotherapy and surgery. Lymph node dissection may remove cancer cells that have spread to nearby lymph nodes in patients with breast cancer. Radiation therapy uses ...

    Continue Reading
  • BESPOKE Study of ctDNA Guided Immunotherapy Colorectal, Melanoma, Non-small Cell Lung Cancer

    This is a prospective data collection study of patients with advanced solid tumors who will receive standard of care immunotherapy (IO) and will be monitored with SIGNATERA™ testing. SIGNATERA™ test will be performed at baseline and during routine care. The test results will be part of assessing tumor response. The correlation between SIGNATERA™ test results and subsequent ...

    Continue Reading
  • BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer Colon, Colorectal

    The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage II or III colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE) tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA™ test results and may be recommended for adjuvant chemotherapy or observation by their treating ...

    Continue Reading
  • The ASH Research Collaborative COVID-19 Registry for Hematology Hematology

    For all information regarding this clinical trial please visit:

    Continue Reading
Page 1 of 3
1-6 of 13 Results